Doceree, a network of physician-only platforms for programmatic messaging used by healthcare organisations worldwide, has today announced the closure of a US$11mn Series A funding round, led by Eight Roads Ventures. The investment firm was backed by Fidelity, with participation also by F-Prime Capital and Alkemi Growth Capital.
As the first global network of healthcare professional-only platforms for programmatic messaging, Doceree supports communication across life science brands and HCPs using a network of point-of-care platforms to deliver messages.
Clear communication will achieve better patient outcomes
Doceree was founded in 2019 by Harshit Jain, who worked as a physician before moving into healthcare marketing. He wanted to create a platform which would enable life sciences brands and media agencies to reach HCPs on their networks, to achieve better patient health outcomes.
With the money from the successful funding round, Doceree plans to upgrade its operations worldwide, build new partnerships, increase its product portfolio and bring greater transparency to its results.
Transforming digital interactions between pharmaceutical brands and prescribers
“It is critical for industry players like life sciences companies and HCP-only platforms to understand and react to the digital touchpoints and behaviours of HCPs for delivering messages they resonate with,” says CEO Jain. “Our identity resolution technology and tailored products for different markets that adhere to the country-specific regulations and guidelines make it easy for life sciences brands to engage with HCPs on digital mediums, while enabling publishers to improve engagement on their platforms with relevant medical information from pharmaceutical and life sciences brands.”
According to Ashish Venkataramani, Partner, Eight Roads Ventures, Doceree is transforming the way digital interactions between pharmaceutical brands and prescribers are facilitated.
“Pharma marketers navigate significant complexity across point-of-care systems and health information systems,” said Venkataramani. “Doceree’s technology platform seeks to disrupt the fragmented value chain for digital messaging to physicians, and will be at the forefront of this promising sector.”
“Doceree has identified a largely overlooked white space in digital pharma marketing and is delivering innovative solutions to address some of the most critical challenges that pharma companies face today,” says Carl Byers, Partner, F-Prime Capital. “We were drawn to the company’s vision and are looking forward to our partnership and continued support as they evolve into their next stage of growth.”